Viewing StudyNCT05155566



Ignite Creation Date: 2024-05-06 @ 4:59 PM
Last Modification Date: 2024-10-26 @ 2:20 PM
Study NCT ID: NCT05155566
Status: COMPLETED
Last Update Posted: 2024-01-26
First Post: 2021-12-09

Brief Title: Treatment Patterns And Clinical Outcomes Among Patients in Latin America Receiving First Line Palbociclib Combinations For HRHER2- AdvancedMetastatic Breast Cancer In Real World Settings
Sponsor:
Organization: Pfizer